Skip to Main Content

Paper Details

Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial).
BMC Cancer
6
2022
Author NameAffiliation
Piero PicciIstituti Ortopedici Rizzoli
Piero PicciIstituti Ortopedici Rizzoli
Uta DirksenWest German Cancer Centre Network Essen-Muenster, University Hospital Essen
Uta DirksenWest German Cancer Centre Network Essen-Muenster, University Hospital Essen
Sandra J StraussUCLH NHS Foundation Trust
  • 1 - 5

Datasets

Release 1.2